Skip to Search
Skip to Navigation
Skip to Content
Skip to Search
Skip to Navigation
Skip to Content
Faculty and Staff

Michael Copenhaver, PhD

Address 358 Mansfield Road Storrs, CT 06269
Phone (860) 486-2846
Links Curriculum Vitae


Research Overview

Dr. Copenhaver is an Associate Professor in the Department of Allied Health Sciences with an emphasis on Health Promotion and is an active Principal Investigator at the Center for Health Intervention and Prevention (CHIP). His current research involves adapting and evaluating evidence-based behavioral interventions that target high risk drug users. He has completed intervention pilot work with opioid-dependent HIV-infected drug users supported by a NIDA K23 career award and has conducted exploratory work (NIDA-funded R21) involving newly-released HIV-infected prisoners. Dr. Copenhaver is completing a randomized clinical trial (NIDA-funded R01) of a community-friendly HIV risk reduction intervention for drug users participating in an inner city methadone maintenance program. He also serves as Co-Investigator on several other NIDA-funded projects both nationally and internationally. Dr. Copenhaver has been at the University of Connecticut since 2002.


Postdoctoral fellow, Yale University, 1999-2000

Ph.D., Virginia Tech, 1999 (clinical psychology)

M.S., Villanova University, 1989 (experimental psychology)

B.A., Clemson University, 1987 (psychology)

Featured Publications

Copenhaver, M., Tunku, N., Ezeabogu, I., Potrepka, J., Zahari, M., Kamarulzaman, A., & Altice, F. (in press 2011). Adapting an Evidence-based Intervention Targeting HIV-infected Prisoners in Malaysia. AIDS Research & Treatment.

Ezeabogu, I., Copenhaver, M., & Potrepka, J. (in press 2011). The Influence of Neurocognitive Impairment on Treatment Outcomes among Drug-involved People Living with HIV/AIDS. AIDS Care.

Copenhaver, M., Lee, I.C , Margolin, A., Bruce, R., & Altice, F. (2011). Testing an Optimized Community-Based Human Immunodeficiency Virus (HIV) Risk Reduction and Antiretroviral Adherence Intervention for HIV-Infected Injection Drug Users, Substance Abuse, 32(1), 16-26.

Copenhaver, M., Lee, I.C., Merz-Beyus, A. & Faghri, P. (2010). The Living Arrangement May Differentially Influence IDU Parents' Motivation to Reduce HIV risk as a Function of Gender. AIDS Care, 22(11), 1373-1378.

Anand, P., Springer, S., Copenhaver, M., & Altice, F. (2010). Neurocognitive Impairment and HIV Risk Factors: A Reciprocal Relationship. AIDS & Behavior, 14, 1213-26.

Copenhaver, M., Chowdhury, S., & Altice, F. (2009). Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: The process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention. AIDS Patient Care & STDs, 23(3), 1-11.

Norton, W., Amico, R., Fisher, W., Copenhaver, M., Cornman, D., Friedland, G., Kozal, M., & Fisher, J. (2008). IDU risk behavior and attitudinal correlates in a sample of HIV-infected patients in clinical care. AIDS Care, 20 (4), 462-469.

Copenhaver, M., Bruce, R., & Altice, F. (2007). Behavioral Counseling Content for Optimizing the Use of Buprenorphine for Opioid Dependence in Community Based Settings: A Review of the Empirical Evidence. American Journal of Drug and Alcohol Abuse, 33, 1-12.

Copenhaver, M., & Lee, I. (2007). Examining the decay of HIV risk reduction outcomes following a community-friendly intervention targeting injection drug users in treatment. Journal of Psychoactive Drugs,39(3).

Copenhaver, M., Lee, I., & Margolin, A. (2007). Successfully integrating HIV risk reduction into a community-based treatment program. American Journal of Drug and Alcohol Abuse, 33(1), 109-120.

Copenhaver, M. & Lee, I. (2006). Optimizing a Community-friendly HIV Risk Reduction Intervention for Injection Drug Users in Treatment: A Structural Equation Modeling (SEM) Approach. Journal of Urban Health, 83(6), 1132-1142.

Copenhaver, M., Johnson, B.T., Lee, I., Carey, M., & Harman, J. (2006). Behavioral HIV risk reduction among injection drug users: Meta-analytic evidence of efficacy. Journal of Substance Abuse Treatment, (31), 163-171.

Copenhaver, M., & Fisher, J. (2006). Experts outline ways to improve the decade-long U.S. trend of 40,000 new HIV infections per year. AIDS & Behavior. (published online 1/06).

Copenhaver, M., Margolin, A., Avants, K., & Warburton, L. (2003). Intervening effectively with drug abusers infected with HIV: Taking into account the potential for cognitive impairment. Journal of Psychoactive Drugs, 35(2), 209-218.

Margolin, A., Kantak, K., Copenhaver, M.M., Avants, K.(2003). A preliminary controlled investigation of magnesium L-aspartate hydrocholoride for illicit cocaine and opiate use in methadone-maintained patients. Journal of Addictive Diseases, 22(2), 49-62.

Copenhaver, M.M. (2000). Testing a social-cognitive model of intimate abusiveness among substance dependent males. American Journal of Drug and Alcohol Abuse, 26(4), 603-628.

about AHS
Uconn is committed to the highest standard of teaching, research and outreach while staying in research and discovery.


Department of Allied Health Sciences
College of Agriculture, Health and Natural Resources
358 Mansfield Road, Unit 1101
Storrs, Connecticut 06269-1101
Telephone: (860) 486-2834
Fax: (860) 486-5375